These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 33576556)

  • 1. Adaptable stewardship during a pandemic: a multifaceted approach to sustaining the blood supply for individuals with sickle cell disease.
    Godby RC; Kornbrust A; Noubouossie D; Kanter J; Ogunsile FJ; Lima JLO; Singh N; Marques MB; Siniard RC
    Int J Lab Hematol; 2021 Aug; 43(4):O168-O170. PubMed ID: 33576556
    [No Abstract]   [Full Text] [Related]  

  • 2. Vulnerability of sickle cell disease persons to the COVID-19 in sub-Saharan Africa.
    Tonen-Wolyec S; Marini Djang'eing'a R; Kambale-Kombi P; Tshilumba CK; Bélec L; Batina-Agasa S
    Hematology; 2020 Dec; 25(1):280-282. PubMed ID: 32657260
    [No Abstract]   [Full Text] [Related]  

  • 3. Severe COVID-19 with acute respiratory distress syndrome (ARDS) in a sickle cell disease adult patient: case report.
    Teulier M; Elabbadi A; Gerotziafas G; Lionnet F; Voiriot G; Fartoukh M
    BMC Pulm Med; 2021 Jan; 21(1):46. PubMed ID: 33514354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Sickle cell anemia and transfusion safety in Bamako, Mali. Seroprevalence of HIV, HBV and HCV infections and alloimmunization belonged to Rh and Kell systems in sickle cell anemia patients].
    Diarra AB; Guindo A; Kouriba B; Dorie A; Diabaté DT; Diawara SI; Fané B; Touré BA; Traoré A; Gulbis B; Diallo DA
    Transfus Clin Biol; 2013 Dec; 20(5-6):476-81. PubMed ID: 23916574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination dose-escalated hydroxyurea and transfusion: an approach to conserve blood during the COVID-19 pandemic.
    Nickel RS; Margulies S; Frazer B; Luban NLC; Webb J
    Blood; 2020 Jun; 135(25):2320-2322. PubMed ID: 32403134
    [No Abstract]   [Full Text] [Related]  

  • 6. Mitigating the effect of the COVID-19 pandemic on sickle cell disease services in African countries.
    Dexter D; Simons D; Kiyaga C; Kapata N; Ntoumi F; Kock R; Zumla A
    Lancet Haematol; 2020 Jun; 7(6):e430-e432. PubMed ID: 32334676
    [No Abstract]   [Full Text] [Related]  

  • 7. Approach to transfusion in pregnant women with sickle cell disease: a survey of physicians.
    Malinowski AK; Parrish J; Shehata N; Ward R; Kuo KHM
    Br J Haematol; 2018 Nov; 183(3):516-519. PubMed ID: 29076147
    [No Abstract]   [Full Text] [Related]  

  • 8. COVID-19 and sickle cell disease.
    Menapace LA; Thein SL
    Haematologica; 2020 Nov; 105(11):2501-2504. PubMed ID: 33131239
    [No Abstract]   [Full Text] [Related]  

  • 9. Initiating adjunct low-dose hydroxyurea therapy for stroke prevention in children with SCA during the COVID-19 pandemic.
    DeBaun MR
    Blood; 2020 May; 135(22):1997-1999. PubMed ID: 32282033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19 in patients with sickle cell disease - a case series from a UK Tertiary Hospital.
    Chakravorty S; Padmore-Payne G; Ike F; Tshibangu V; Graham C; Rees D; Stuart-Smith S
    Haematologica; 2020 Nov; 105(11):2691-2693. PubMed ID: 33131264
    [No Abstract]   [Full Text] [Related]  

  • 11. Optimal Manual Exchange Transfusion Protocol for Sickle Cell Disease: A Retrospective Comparison of Two Comprehensive Care Centers in the United Kingdom and Canada.
    Mian HS; Ward R; Telfer P; Kaya B; Kuo KH
    Hemoglobin; 2015; 39(5):310-5. PubMed ID: 26114740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 infection in patients with sickle cell disease.
    Hussain FA; Njoku FU; Saraf SL; Molokie RE; Gordeuk VR; Han J
    Br J Haematol; 2020 Jun; 189(5):851-852. PubMed ID: 32314798
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of transfusion practices in sickle cell disease in Senegal: cohort study of 1078 patients with sickle cell disease.
    Seck M; Tall A; Faye BF; Bah DS; Guéye Y; Sall A; Touré AO; Diop S
    Med Sante Trop; 2017 Nov; 27(4):402-406. PubMed ID: 29313508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transfusion support in patients with sickle cell disease.
    Sharma D; Ogbenna AA; Kassim A; Andrews J
    Semin Hematol; 2020 Apr; 57(2):39-50. PubMed ID: 32892842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of COVID-19 Infection on 24 Patients with Sickle Cell Disease. One Center Urban Experience, Detroit, MI, USA.
    Balanchivadze N; Kudirka AA; Askar S; Almadhoun K; Kuriakose P; Fadel R; Dabak V
    Hemoglobin; 2020 Jul; 44(4):284-289. PubMed ID: 32722950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Care of patients with hemoglobin disorders during the COVID-19 pandemic: An overview of recommendations.
    Taher AT; Bou-Fakhredin R; Kreidieh F; Motta I; De Franceschi L; Cappellini MD
    Am J Hematol; 2020 Aug; 95(8):E208-E210. PubMed ID: 32394480
    [No Abstract]   [Full Text] [Related]  

  • 17. Sickle-cell disease and pregnancy.
    Tuck SM
    Br J Hosp Med; 1982 Aug; 28(2):125-7. PubMed ID: 7126979
    [No Abstract]   [Full Text] [Related]  

  • 18. Transfusion management in sickle cell disease.
    Wanko SO; Telen MJ
    Hematol Oncol Clin North Am; 2005 Oct; 19(5):803-26, v-vi. PubMed ID: 16214645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Letter to the Editor: Physicians' Opinions of COVID-19 Ambulatory Care Constraints: A Survey of Sickle Cell Clinicians.
    Kenney MO; Becerra B; Beatty SA; Smith W
    J Ambul Care Manage; 2021 Oct-Dec 01; 44(4):325-330. PubMed ID: 34120124
    [No Abstract]   [Full Text] [Related]  

  • 20. Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood.
    Vichinsky EP; Earles A; Johnson RA; Hoag MS; Williams A; Lubin B
    N Engl J Med; 1990 Jun; 322(23):1617-21. PubMed ID: 2342522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.